Viewing Study NCT06622668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-25 @ 6:38 PM
Study NCT ID: NCT06622668
Status: WITHDRAWN
Last Update Posted: 2025-01-17
First Post: 2024-09-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
Sponsor: Intellia Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Disease View
None Pulmonary Disease View
None AATD View
None Alpha-1 Antitrypsin Deficiency View
None Alpha-1 Antitrypsin Deficiency-associated Lung Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AATD View